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Introduction
Previous studies have reported that  associations 
of cardiovascular mortality with particle pollu-
tion (Zanobetti and Schwartz 2001; Zanobetti 
et al. 2009) and extreme ambient tempera-
tures during heat waves (Medina-Ramón 
et al. 2006; Schifano et al. 2009; Schwartz 
2005) are stronger in persons with diabetes 
than in those without diabetes. It has been 
hypothesized that people with diabetes are at 
greater risk for acute environmental perturba-
tions of vascu lar (including coronary artery) 
function because of chronic endothelial dys-
function, autonomic dys regulation, atheroscle-
rosis, or dysregulation of fluid balance and the 
renin–angiotensin system (Pop-Busui 2010; 
Ribeiro-Oliveira et al. 2008). Common medi-
cations such as angiotensin-converting enzyme 
(ACE) inhibitors may further block appro-
priate compensatory autoregulatory responses 
(Bell 2009) to hypertensive or to orthostatic 
hypotensive changes in blood pressure and 
vascular diameter.
Basel ine brachial  artery diameter 
(BAD), flow-mediated dilation (FMD), and 
nitroglycerin-mediated dilation (NMD) have 
been used as intermediate outcomes in stud-
ies of cardiovascular responses to pollution 
in controlled human exposure (Brook et al. 
2002) and observational research (Moens 
et al. 2005). As predictors of cardiac risk and 
coronary artery function, BAD (Montalcini 
et al. 2012) and FMD (Caballero et al. 1999; 
Gold 2008; Liu et al. 2007; Sullivan et al. 
2003) have clinical as well as physiologic rele-
vance. FMD, a measure of the difference in 
BAD after brachial artery occlusion relative 
to baseline BAD (before occlusion), reflects 
the combined effects of endothelial- dependent 
processes that influence the production and 
quenching of vasodilatory nitrogen oxide 
(NO) and endothelial-independent processes 
that influence vascular smooth muscle respon-
siveness to NO (Ghio et al. 2000; Salvi et al. 
1999; Sørensen et al. 2003). Nitroglycerin-
mediated dilation (NMD), a measure of the 
change in BAD before and after administra-
tion of nitroglycerin (an exoge nous source 
of NO), reflects autonomic vascular smooth 
muscle responsiveness occurring independently 
of endothelial NO production. A decrease in 
FMD but not NMD suggests an effect on 
endothelial function specifically, whereas a 
decrease in both outcomes suggests that part or 
all of the change is due to endothelial-indepen-
dent effects. People with diabetes have mark-
edly reduced but measura ble FMD (Caballero 
et al. 1999). In a previous cross-sectional study 
of Boston, Massachusetts, USA, residents, 
we found that short-term increases in traffic 
and non-traffic pollution were associated with 
reduced FMD and NMD in participants with 
type 2 diabetes (O’Neill et al. 2005), suggest-
ing both non-endothelial– and endothelial-
mediated mechanisms for pollution-related 
vascular dysfunction.
High humidity has been associated with 
hyperpyrexia, a decline in physical strength 
and fatigue as well as a reduction in alertness 
Address correspondence to A. Zanobetti, Department 
of Environmental Health, Exposure Epidemiology 
and Risk Program, Harvard School of Public Health, 
401 Park Dr., Landmark Center, Suite 415, P.O. 
Box 15698, Boston, MA 02215 USA. Telephone: 
(617) 384-8751. E-mail: azanobet@hsph.harvard.edu
Supplemental Material is available online (http://
dx.doi.org/10.1289/ehp.1206136).
This study was funded by the National Institute of 
Environmental Health, National Institutes of Heath 
(grants PO1 ES-09825 and R21ES020194-01) and 
by the U.S. Environmental Protection Agency (EPA; 
grants RD-83241601 and RD-83479801. 
The contents of this publication are solely the 
responsibility of the grantee and do not necessarily 
represent the official views of the U.S. EPA. Further, 
the U.S. EPA does not endorse the purchase of any 
commercial products or services mentioned in this 
publication.
The authors declare they have no actual or potential 
competing financial interests.
Received: 12 October 2012; Accepted: 3 January 
2014; Advance Publication: 7 January 2014; Final 
Publication: 1 March 2014.
Brachial Artery Responses to Ambient Pollution, Temperature, and Humidity 
in People with Type 2 Diabetes: A Repeated-Measures Study
Antonella Zanobetti,1 Heike Luttmann-Gibson,1 Edward S. Horton,2 Allison Cohen,2 Brent A. Coull,3 
Barbara Hoffmann,4 Joel D. Schwartz,1 Murray A. Mittleman,5 Yongsheng Li,2 Peter H. Stone,6 Celine de Souza,1 
Brooke Lamparello,2 Petros Koutrakis,1 and Diane R. Gold1,7
1Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, USA; 2Joslin Diabetes Center, Boston, 
Massachusetts, USA; 3Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA; 4IUF Leibniz Research 
Institute for Environmental Medicine and Medical School, University of Düsseldorf, Düsseldorf, Germany; 5Beth Israel Deaconess 
Medical Center, Harvard Medical School, Boston, Massachusetts, USA; 6Department of Medicine, Brigham and Women’s Hospital, 
Harvard Medical School, Boston, Massachusetts, USA; 7Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, 
Harvard Medical School, Boston, Massachusetts, USA
Background: Extreme weather and air pollution are associated with increased cardiovascular risk 
in people with diabetes.
oBjectives: In a population with diabetes, we conducted a novel assessment of vascular brachial 
artery responses both to ambient pollution and to weather (temperature and water vapor pressure, a 
measure of humidity).
Methods: Sixty-four 49- to 85-year-old Boston residents with type 2 diabetes completed up to 
five study visits (279 repeated measures). Brachial artery diameter (BAD) was measured by ultra-
sound before and after brachial artery occlusion [i.e., flow-mediated dilation (FMD)] and before 
and after nitroglycerin-mediated dilation (NMD). Ambient concentrations of fine particulate mass 
(PM2.5), black carbon (BC), organic carbon (OC), elemental carbon, particle number, and sulfate 
were measured at our monitoring site; ambient concentrations of carbon monoxide, nitrogen 
dioxide, and ozone were obtained from state monitors. Particle exposure in the home and during 
each trip to the clinic (home/trip exposure) was measured continuously and as a 5-day integrated 
sample. We used linear models with fixed effects for participants, adjusting for date, season, 
temperature, and water vapor pressure on the day of each visit, to estimate associations between our 
outcomes and interquartile range increases in exposure.
results: Baseline BAD was negatively associated with particle pollution, including home/trip– 
integrated BC (–0.02 mm; 95% CI: –0.04, –0.003, for a 0.28 μg/m3 increase in BC), OC 
(–0.08 mm; 95% CI: –0.14, –0.03, for a 1.61 μg/m3 increase) as well as PM2.5, 5-day average 
ambient PM2.5, and BC. BAD was positively associated with ambient temperature and water vapor 
pressure. However, exposures were not consistently associated with FMD or NMD.
conclusion: Brachial artery diameter, a predictor of cardiovascular risk, decreased in association with 
particle pollution and increased in association with ambient temperature in our study population of 
adults with type 2 diabetes.
citation: Zanobetti A, Luttmann-Gibson H, Horton ES, Cohen A, Coull BA, Hoffmann B, 
Schwartz JD, Mittleman MA, Li Y, Stone PH, de Souza C, Lamparello B, Koutrakis P, Gold DR. 
2014. Brachial artery responses to ambient pollution, temperature, and humidity in people with 
type 2 diabetes: a repeated-measures study. Environ Health Perspect 122:242–248; http://dx.doi.
org/10.1289/ehp.1206136
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and mental capacity. High humidity often 
occurs when temperature is high, and the 
effects of the two exposures can be difficult to 
disentangle (Sharma et al. 1983). In Germany, 
Schneider et al. (2008b) analyzed the influ-
ence of weather parameters [including water 
vapor pressure (WVP)] on blood pressure, 
arrhythmia, and ischemia in cardiovascular 
patients. Schneider et al. (2008b) noted that 
the associations they detected between weather 
parame ters and ST-segment depression could 
be relevant to clinical cardio vascular outcomes.
In a prospective, repeated-measures study, 
we investigated associations of BAD, FMD, 
and NMD with pollutant exposures, ambient 
temperature, and humidity in 64 adults with 
type 2 diabetes.
Materials and Methods
Study population and protocol. The study 
population consisted of Boston residents with 
type 2 diabetes mellitus who lived within 
25 km of a central air monitoring site located 
near downtown Boston. Participants were 
recruited between 2006 and 2009. If they 
met initial screening criteria, they were invited 
to come for a baseline visit that included an 
interview on socio demographic characteris-
tics, health status, medical history, medication, 
and lifestyle; blood and urinary analysis; and 
a clinical examination. This visit provided an 
opportunity both for further detailed screen-
ing and for collecting baseline data on par-
ticipants who after the visit were found to be 
eligible for the follow-up study. Exclusion 
criteria focused on factors that can introduce 
particle exposure errors (e.g., exposure to 
second-hand tobacco smoke at home; living 
> 25 km from the central monitoring station); 
taking medications with acute vascular effects; 
having conditions with electro physiological 
or vascu lar effects [i.e., current atrial 
fibrillation/ flutter; history of clinically signifi-
cant ventricu lar arrhythmias, a pacemaker or 
an implanted defibrillator; acute myocardial 
infarction or stent placement within the last 
6 months]; on clinical/ biomarker parameters 
requiring immediate attention [e.g., uncon-
trolled hypertension (systolic blood pressure 
> 180 mmHg, diastolic blood pressure 
> 105 mmHg)]; having markers of poor 
diabetes/lipid control or advanced diabetic 
nephropathy [serum cholesterol > 350 mg/dL, 
serum triglycerides > 600 mg/dL, hemoglobin 
A1c (HbA1c) > 10.5%; fasting blood glucose 
> 270 mg/dL; urine albumin/creatinine ratio 
> 300 μg/dL], and having diagnoses of other 
advanced diseases (e.g., solid organ trans-
plant, active autoimmune disease, dementia, 
type 1 diabetes, renal failure, seizure disorder, 
or stroke).
After entry into the follow-up study, eli-
gible participants completed up to five follow-
up clinical examinations scheduled 2 weeks 
apart on the same weekday in the morning. 
We ascertained medication use by patient 
self-report at baseline and at each subsequent 
visit. The study protocol was approved by the 
institutional review boards of the Brigham 
& Women’s Hospital, the Joslin Diabetes 
Clinic, and the Harvard School of Public 
Health. All participants provided written 
informed consent.
At each visit BAD, FMD, and NMD 
were measured by ultrasound according to 
standardized protocols. Participants were 
placed in the supine position with the right 
arm abducted by approximately 60° and 
comfortably placed on a support. For the 
assessment of endothelial-dependent vaso-
dilatation (i.e., FMD), a pneumatic tourni-
quet was placed on the right forearm 2 cm 
below the antecubital fossa. After a 15-min 
rest period, high-resolution brachial artery 
ultrasound was performed to measure BAD 
with a 10-MHz linear-array transducer 
and a Terason 2000 ultrasound (Teratech 
Corporation, Burlington, MA, USA) with 
electrocardiogram- gated image acquisition 
at end diastole. After taking baseline images, 
the arm was immobilized and the transducer 
was held in a fixed position throughout the 
assessment. Reactive hyperemia was pro-
duced by inflating the tourniquet to approxi-
mately 50 mmHg above the individual’s 
systolic blood pressure for 5 min and then 
quickly deflating it (Celermajer et al. 1992). 
Ultrasound picture acquisition was repeated 
60 sec after sudden deflation for 10 sec.
After another 15-min rest period, 
endothelium- independent vasodilatation (i.e., 
NMD) was assessed by measuring BAD before 
and 3 min after the sublingual administra-
tion of 0.4 mg nitroglycerin. Blood pressure 
and heart rate were monitored in the left arm 
before and after the brachial artery measure-
ments and before and after nitro glycerin 
administration. NMD was not performed if 
systolic blood pressure was < 90 mmHg. All 
acquired ultrasound images were analyzed 
centrally according to a predefined protocol 
using Brachial Analyzer Vascular Research 
Tools 5, version 5.6.12 (Medical Imaging 
Applications LLC, Coralville, IA, USA). FMD 
and NMD are expressed as percent change in 
BAD [i.e., BAD after the intervention (occlu-
sion or nitroglycerin) minus the BAD before 
the intervention, divided by the BAD before 
the intervention].
Environmental data. Ambient concentra-
tions of fine particle mass [with aerodynamic 
diameter < 2.5 μm (PM2.5)], black carbon 
(BC), organic carbon (OC), elemental carbon 
(EC), particle number concentration (PN), 
and sulfate (SO42–) were measured hourly at 
a central monitoring site (Harvard Supersite) 
in Boston, Massachusetts. Hourly ambient 
concentrations of ozone (O3), carbon 
monoxide (CO) and nitrogen dioxide (NO2) 
were estimated by averaging data from the 
Massachusetts Department of Environmental 
Protection’s Greater Boston monitoring sites. 
Missing hourly data for PM2.5 and BC were 
imputed using regression modeling, includ-
ing a long-term time trend and day of week, 
hour of day, temperature, relative humidity, 
barometric pressure, and NO2 as predictors. 
OC, EC, and SO42– were not available in 
2006 and for part of 2010; this resulted in 
approximately 20% missing values. All other 
exposure variables (both weather parameters 
and pollution) had few missing values (< 1%), 
which were assumed to be missing at random.
OC can be both primary and secondary. 
Using published methods (Lim and Turpin 
2002), we estimated primary OC (emitted 
by cars) by multiplying EC by 1.8, and esti-
mated secondary OC (due to oxidation of 
traffic emissions as well as biogenic emissions) 
as OC minus primary OC.
Pollutant exposures were averaged over 
24-hr intervals (0900–0900, to correspond to 
the time of arrival at the study clinic for each 
visit). In addition, we derived average expo-
sures over the previous 1–6 days when ≥ 75% 
of daily data were available.
We also estimated individual PM2.5 and 
BC exposures. Five days before each clinic 
visit, fine particle samplers were placed in 
each study participant’s home. On the day 
of the visit, the participant brought the pollu-
tion samplers (still in operation) to the clinic. 
A custom-made Harvard sampling system 
was used to collect fine particles (i.e., PM2.5) 
on Teflon filters to determine PM2.5 and 
BC mass concentration (by gravimetry and 
reflectance, respectively) as a measure of 5-day 
home/trip– integrated exposures. The sam-
pling system also included a SidePak (model 
AM510; TSI Inc., Shoreview, MN, USA) 
that provided continuous measurements of 
PM2.5 particle mass concentration, calibrated 
using the integrated PM2.5 filter to derive 
hourly averages, 24-hr averages, and moving 
averages of up to 5 days when ≥ 75% of daily 
(or hourly) data were available.
Weather parameters, including hourly 
temperature, barometric pressure, and dew 
point temperature, were obtained from the 
National Weather Service Station at Logan 
Airport (Boston, MA, USA), located approxi-
mately 12 km from the examination site. 
WVP (actual water vapor pressure), a mea-
sure of humidity defined as the amount of 
water vapor in a volume of air, increases as 
the amount of water vapor increases. WVP 
(hPa) was computed as WVP = 6.1078 × 
10(7.5 × dewpoint)/(237.7 + dewpoint) (Barenbrug 
1974; Buck 1981; Eaton and Kells 2009). 
Temperature and WVP were also evaluated as 
24-hr averages (0900–0900) and as cumula-
tive averages over the previous 1–5 days.
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Statistical analysis. We estimated the 
associations of air pollution and weather with 
the individual BAD measurements performed 
during each visit as separate outcomes: BAD 
before occlusion, BAD after occlusion, BAD 
before sublingual nitroglycerin administra-
tion, and BAD after sublingual nitroglycerin 
administration. In addition, we estimated 
associations with FMD (i.e., the percent 
change in BAD in response to occlusion) and 
NMD (i.e., the percent change in BAD in 
response to nitroglycerin administration).
We fit linear models for each outcome that 
included fixed effects for participant and linear 
terms for the date of visit, season, and the aver-
age temperature on the day of each visit. The 
indicator variables for each participant control 
for correlated measurements within subjects, 
and for confounding by time invariant charac-
teristics such as gender and ethnicity. Baseline 
and end-of-study glucose control (i.e., HbA1c) 
was measured using standard methods. When 
HbA1c was included in our model as a lin-
ear variable, it was not a significant predictor 
of our outcomes, did not improve our model 
fit, and, therefore, was not included in the 
final models. Model residuals were normally 
 distributed (data not shown).
Both fixed and random effects approaches 
to estimation were based on the same 
model, so the implied correlation structure 
among repeated measurements is similar in 
the two models. Hence, a fixed intercept 
for each participant fully accounts for the 
within- correlation of the repeated data for 
each participant. In mixed effects models, 
the estimated exposure effect is a blend of 
cross-sectional (across subject) and longitu-
dinal (within subject) comparisons. Because 
of the cross-sectional component, the esti-
mates can be subject to confounding by 
charac teristics specific to that participant (e.g., 
socio economic status). In contrast, the fixed 
effect estimates are based purely on longi-
tudinal comparisons, which make them not 
subject to between-subject confounding. This 
is the primary reason we used fixed effects 
in this application (Fitzmaurice et al. 2004). 
Because we did not want our reported results 
to be highly dependent on the chosen model, 
we fit the analogous mixed effects models in 
sensitivity analyses.
Effect estimates were scaled by the inter-
quartile pollutant range (IQR). Estimates for 
pollution associations with BAD (before and 
after occlusion, and before and after sublingual 
nitroglycerin administration) are presented 
as a change in BAD in millimeters per IQR 
increase in pollution. Estimates for pollution 
associations with FMD and NMD are pre-
sented as change FMD or NMD in percent 
per IQR increase in pollution levels.
We focused on associations with expo-
sures occurring in the 1–6 days before coming 
to the clinic because of evidence from prior 
studies (Hoffmann et al. 2012; O’Neill et al. 
2005) and biologic priors [ vascular autonomic 
responses to pollutants could be relatively 
immediate (within 24 hr)], whereas inflamma-
tory vascular responses would be cumulative 
over a week. With temperature, our previ-
ous analytic experience also suggested more 
immediate responses related to temperature in 
the 24 hr before the measurement, along with 
approximately 1-week cumulative responses 
that could relate effects of persistent episodes 
of high or low temperature (Hoffmann et al. 
2012). We estimated associations of our out-
comes with cumulative exposures of up to 
14 days, to assess how the associations varied 
with longer moving averages, and because par-
ticipants completed clinic visits every 2 weeks. 
When interpreting our findings, we focused on 
the consistency of associations among corre-
lated pollutants (e.g., different markers of traf-
fic-related pollution). We estimated the effects 
of temperature, barometric pressure, and WVP 
with and without adjustment for particle expo-
sures (5-day average PM2.5 and BC), using the 
same model described above. We first tested 
the relationship between the meteoro logical 
variables and our outcomes with a penalized 
spline. Because the generalized cross valida-
tion (GCV) method estimated one degree of 
freedom for the penalized spline of the weather 
parameters and these showed a linear pattern, 
we then included the meteorological variables 
linearly in the models.
Results for weather parameters are pre-
sented as the change in BAD (in milli meters), 
FMD and NMD (in percent) associated with 
an IQR increase in each parameter. To esti-
mate short-term and cumulative effects of 
weather, we modeled individual daily averages 
and cumulative averages from the day of the 
visit up to and including 5 days before the visit.
We examined effect modification by ACE 
inhibitors and beta-blockers by including an 
interaction term between the 5-day average of 
each exposure and the medication variables. 
Medication use was ascertained by patient 
self-report at baseline and at each subsequent 
visit. We also examined effect modification 
by patient characteristics such as body mass 
index (BMI) in four categories: underweight 
(BMI < 18.5); normal (18.5 ≥ BMI < 25); 
overweight (25 ≥ BMI < 30); obese (BMI 
≥ 30), gender, and continuous HbA1c. Finally, 
we examined effect modifi cation of associa-
tions with temperature by season—defined 
as winter (December–February), spring 
(March–May), summer (June–August), and 
autumn (September–November)—by includ-
ing an interaction term between temperature 
and season.
In two-pollutant models, we included two 
pollutants at a time together in each model.
All analyses were performed using R, 
version 2.14.1 (The R Project for Statistical 
Computing, Vienna, Austria).
Results
During the study period (September 2006 
to July 2010), 70 participants were enrolled 
in the repeated-measures study. Of these, 
64 had complete covariate information 
with ≥ 1 acceptable FMD evaluation over 
a total of 279 visits (Table 1). A subset of 
Table 1. Participant characteristics.
Characteristic Participants (n) Observations (n) Percent Mean (range)
Age (years) 64 64 63.9 (45–81)
BMI (kg/m²) 64 64 31.5 (20.5–57.2)
Years with diabetes 62 10.4 (1–38)
Male 32 50
Female 32 50
Medicationa
β-blocker 24 38
Calcium-channel blocker 15 23
ACE inhibitor 29 45
Statin 50 78
Insulin 9 14  
Study visits completed
1 64 100
2 60 94
3 57 89
4 54 84
5 44 69
BAD (mm)b
Baseline 64 279 4.5 (2.5–6.23)
After occlusion 64 279 4.6 (2.6–6.3)
Before nitroglycerin 43 164 4.4 (2.6–6.3)
After nitroglycerin 43 159 4.9 (3.02–6.9)
FMD (%) 64 279 2.0 (–4.6–14.2)
NMD (%) 43 159 10.0 (–0.4–21.3)
Mean values are averaged across all study visits.
aMedication use was ascertained by patient self-report at baseline and at each subsequent visit. bBaseline refers to 
BAD measured before brachial artery occlusion. BAD before and after nitroglycerine refers to measures taken before 
and after sublingual administration of nitroglycerine.
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43 participants (159 observations) consented 
and had blood pressures within a range that 
allowed us to administer nitroglycerin and 
measure NMD. The participants had an equal 
distribution by gender, on average a long-
standing history of diabetes (mean, 10 years), 
and an average BMI of 31 kg/m². The base-
line BAD (i.e., the BAD measurement taken 
before brachial artery occlusion) across all par-
ticipants ranged between 2.5 and 6.2 mm, 
with a mean of 4.1 mm (range, 2.5–5.2 mm) 
in women, and 5.0 mm (range, 3.6–6.2 mm) 
in men. Although the BAD was comparable to 
what we have previously measured in healthy 
adults without diabetes, as expected in our 
diabetic cohort, the FMD and NMD were 
markedly reduced (Brook et al. 2009).
Table 2 summarizes the distribution of the 
pollutant concentrations and of temperature 
values for the 24-hr and 5-day averages. For 
most exposures, data were complete (or nearly 
so) for all 279 visit days included in the pres-
ent analysis. However, for OC and EC, 24-hr 
averages measures were available for only 231 
of the 279 days, and for SO42–, 24-hr aver-
ages were available for 197 days (Table 2). 
Table S1 in the Supplemental Material shows 
the correlations among pollutant and meteoro-
logical variables, PM2.5, BC, OC, EC, and 
SO42–, were highly correlated with each other 
but were not highly correlated with PN count, 
O3, or temperature. The home/trip– integrated 
concentrations for BC and PM2.5 were not 
highly correlated with their respective ambient 
concentrations. The average 24-hr maximum 
PM2.5 concentration (27 μg/m3) was below the 
National Air Quality Standard recommended 
upper limit of 35 μg/m3 (U.S. Environmental 
Protection Agency 2014).
Pollution and BAD. Figure 1 presents 
the associations of the mean 5-day average 
concentrations of each of the pollutants with 
BAD before brachial artery occlusion, and 
before sublingual nitroglycerin administra-
tion. We focus on results related to the 5-day 
moving averages because we found the largest 
and most consistent associations of BAD or 
FMD with the 4 and 5 days moving aver-
ages of pollution. A second rationale for this 
choice is that the indoor/trip–integrated BC 
and PM2.5 were measured from the filters that 
represented an integrated particle collection 
over a 5-day period.
Baseline BAD was negatively associated 
with increases in particle mass and BC and 
OC particle components (Figure 1). Scaling 
for the IQR increases in pollution levels, a 
0.25 μg/m3 increase in 5-day mean ambient 
BC was associated with a –0.035-mm decrease 
(95% CI: –0.07, 0.00) in baseline BAD. 
Baseline BAD also decreased in association 
with IQR increases in 5-day average expo-
sures to ambient PM2.5 (–0.02 mm; 95% CI: 
–0.05, 0.01, IQR = 3.14 μg/m3), ambient 
Table 2. Air pollution, temperature, and water vapor pressure among all observations (24-hr average and 
5-day average values before each study visit).
Variable
Observations 
(n) Mean
Percentile
Maximum IQR25th 50th 75th
Ambient PM2.5 (μg/m3)
24 hr 278 8.37 5.52 7.38 9.58 26.69 4.06
5 day 279 8.51 6.47 7.61 9.62 21.10 3.14
Indoor continuous PM2.5 (μg/m3)
24 hr 258 7.11 3.73 5.04 7.96 56.43 4.23
5 day 260 8.93 5.02 7.11 10.51 52.88 5.49
Home/trip–integrated PM2.5 (μg/m3)
5 day 269 9.18 5.05 7.74 10.70 57.28 5.66
Ambient BC (μg/m3)
24 hr 279 0.61 0.41 0.54 0.76 2.62 0.35
5 day 279 0.60 0.48 0.57 0.73 1.25 0.25
Home/trip–integrated BC (μg/m3)
5 day 268 0.77 0.56 0.69 0.84 4.89 0.28
OC (μg/m3)
24 hr 231 3.03 2.07 2.85 3.82 8.91 1.75
5 day 245 3.03 2.17 2.98 3.78 6.24 1.61
EC (μg/m3)
24 hr 231 0.35 0.24 0.30 0.44 0.96 0.20
5 day 245 0.34 0.27 0.34 0.41 0.80 0.14
CO (ppm)
24 hr 279 0.28 0.21 0.27 0.34 1.00 0.13
5 day 279 0.28 0.23 0.28 0.33 0.52 0.10
NO2 (ppm)
24 hr 279 0.015 0.011 0.015 0.018 0.033 0.006
5 day 279 0.015 0.012 0.014 0.016 0.025 0.004
O3 (ppm)
24 hr 279 0.027 0.020 0.026 0.032 0.061 0.012
5 day 279 0.028 0.022 0.028 0.033 0.047 0.010
PN (1,000/cm3)
24 hr 262 13.27 9.03 12.47 17.21 32.67 8.18
5 day 265 12.95 8.92 12.43 16.16 28.39 7.24
SO42– (μg/m3)
24 hr 197 2.13 0.95 1.61 2.41 12.34 1.47
5 day 221 2.28 1.37 1.82 2.72 7.08 1.34
Temperature (°C)
24 hr 279 13.71 6.84 14.78 21.20 29.33 14.36
5 day 279 13.68 6.84 15.10 20.99 26.39 14.15
Water vapor pressure (hPa)
24 hr 279 11.41 6.18 10.53 16.32 24.99 10.14
5 day 279 11.49 6.72 10.63 16.06 24.63 9.34
Summary data were based on imputed data for ambient PM2.5 and ambient BC.
Figure 1. Estimated changes in BAD (in mm) associated with IQR increases in mean 5-day concentrations 
of each pollutant, including BAD measured at baseline, and before sublingual nitroglycerin administration. 
Error bars represent 95% CIs.
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OC (–0.08 mm; 95% CI: –0.14, –0.03, 
IQR = 1.61 μg/m3), indoor/trip– integrated 
BC (–0.02 mm; 95% CI: –0.04, –0.003, 
IQR = 0.28 μg/m3), and indoor/trip–
integrated PM2.5 (–0.04 mm; 95% CI: 
–0.06,  –0.01,  IQR = 5.66 mg/m3). 
Associations with increases in the same expo-
sures during the previous 24 hours, or as 
cumulative averages over shorter or longer 
time periods (up to 6 days) (see Supplemental 
Material, Figure S1) were generally weaker 
than associations with 5-day average values. 
To assess for relatively immediate responses 
on pollution during the trip to the clinic, 
using the home/trip– continuous PM2.5 
exposures, we also explored associations of 
shorter averages of PM (30, 60, and 90 min 
before the visit) on the day of the visit, but 
found no associa tions with our outcomes 
(data not shown).
Associations of baseline BAD with IQR 
increases in 5-day mean concentrations of 
EC, CO, and NO2, were negative but non-
significant, and baseline BAD was not asso-
ciated with 5-day mean SO42– or O3 (see 
Supplemental Material, Figure S2).
Associations of pollution with brachial 
artery narrowing tended to weaken after the 
maneuvers designed to cause brachial artery 
dilation (shear stress after arterial occlusion or 
sublingual nitroglycerin). However, despite 
perturbation of vascular function by the 
FMD and NMD maneuvers, the previous 
5-day exposures to particle pollution tended 
to have a relatively persistent association 
with brachial artery narrowing for measures 
of BAD conducted after occlusion, before or 
after sub lingual nitroglycerin administration 
(Figure 1; see also Supplemental Material, 
Figure S3). For example, the previous 5-day 
home/trip–integrated PM2.5 was associated 
with reduced BAD before and after the FMD 
maneuver, as well as immediately before the 
NMD maneuver (see Supplemental Material, 
Figure S3).
In two-pollutant models, the magnitude 
and statistical significance of associations of 
baseline BAD with 5-day mean PM2.5 and 
BC remained essentially unchanged, whereas 
there were no significant associations with 
5-day mean values of NO2 or O3 based on 
two-pollutant models (data not shown).
Associations of 5-day mean PM2.5 and 
BC concentrations with baseline BAD were 
stronger (pinteraction = 0.01) in participants 
taking ACE inhibitors. For example, a 
3.14-mg/m3 increase in 5-day average PM2.5 
was not associated with baseline BAD among 
the 35 participants who were not taking ACE 
inhibitors (0.008 mm; 95% CI: –0.3, 0.04), 
but baseline BAD was significantly lower 
among the 29 participants who were tak-
ing ACE inhibitors (–0.06 mm; 95% CI: 
–0.11, –0.02). There was no evidence 
(pinteraction = 0.7) of effect modification by 
beta-blocker use (data not shown).
In sensitivity analyses, we compared fixed 
with mixed effect models and found that the 
main results, as well as the effect modification 
results by medications, were very similar (data 
not shown). We also found that the associa-
tions of BAD and FMD with each pollutant 
were similar in the smaller group of 42 par-
ticipants who had both FMD and NMD 
measures compared with the larger group of 
64 participants who had FMD measures (data 
not shown).
Temperature, humidity, and BAD . 
Baseline BAD increased in association 
with IQR increases in same-day tempera-
ture (0.12 mm; 95% CI: 0.04, 0.19, 
IQR = 14.4°C) and WVP (0.09 mm; 95% CI: 
0.02, 0.16, IQR = 10.13 hPa) when estimated 
using separate models. When temperature 
and WVP were included in the same model, 
WVP was no longer significantly associated 
with baseline BAD (0.06 mm; 95% CI: 
–0.06, 0.17) and the association with tem-
perature was attenuated (0.09 mm; 95% CI: 
0.0, 0.18). However, these estimates are diffi-
cult to interpret given the high correlation 
between temperature and WVP (r = 0.88). 
Associations between temperature and baseline 
BAD were similar when adjusted for 5-day 
PM2.5 or BC (Figure 2). Associations of tem-
perature with BAD after NMD were also in 
a positive direction but smaller in magnitude 
and lower in precision. The associations of 
same day temperature with baseline BAD were 
stronger during autumn and summer, and 
lower in spring and winter (Figure 2).
Pollution, temperature, humidity, FMD, 
and NMD. While the FMD and the NMD 
tended to increase with increases in pollut-
ant concentrations, the changes with pollu-
tion were small, inconsistent, and generally 
non significant (Table 3). Temperature was 
not associated with FMD or NMD (data 
not shown), and barometric pressure was 
not associated with baseline BAD, FMD, or 
NMD (results not shown).
Discussion
As well as demonstrating an association of 
elevated particle pollution with change in 
BAD, to the best of our knowledge this is 
the first longitudinal study of people with 
type 2 diabetes to estimate associations of 
BAD with temperature, now recognized in its 
extremes as a predictor of cardiovascular risk 
(Montalcini et al. 2012). Our study results 
suggest that for this cohort of people with 
diabetes, particle pollution was a brachial 
artery vasoconstrictor, whereas higher ambi-
ent temperature and, perhaps, high humidity 
were brachial artery vasodilators.
Our study, demonstrating sub clinical asso-
ciations of pollution and weather with changes 
in BAD, gives us insight into potential mecha-
nisms for the clinical effects of more extreme 
exposures on popu lations potentially at risk 
of particle- and temperature- related health 
effects. Evidence from multiple epidemiologi-
cal studies suggests that people with diabetes 
may be more susceptible to the joint and sepa-
rate effects of temperature and air pollution 
on cardio vascular morbidity and mortality 
(Medina-Ramón et al. 2006; Qian et al. 
2010; Schifano et al. 2009; Schwartz 2005; 
Zanobetti and Schwartz 2001; Zanobetti 
et al. 2009).
Potential mechanisms. BAD is influenced 
by structural (e.g., athero sclerotic), endothelial-
dependent (e.g., NO producing), and 
endothelial-independent (e.g., autonomic) 
factors. The short-term associations between 
Figure 2. Estimated changes in BAD (in mm) asso-
ciated with an IQR increase in average daily tem-
perature during the 24 hr before the study visit with 
and without adjustment for PM2.5, or BC by season, 
for baseline BAD (measured before occlusion). 
Error bars represent 95% CIs.
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Table 3. Associations of FMD and NMD with IQR increases (µg/m3) in the 5-day mean concentrations of 
each pollutant.
Exposure IQR FMD (95% CI) NMD (95% CI)
Ambient BC 0.25 0.41 (–0.09, 0.91) –0.62 (–1.56, 0.31)
Home/trip–integrated BC 0.28 0.38 (0.11, 0.65) –0.08 (–0.65, 0.49)
Ambient PM2.5 3.14 0.37 (–0.04, 0.77) 0.03 (–0.74, 0.80)
Home/trip
Continuous PM2.5 5.40 0.08 (–0.25, 0.42) 0.75 (0.20, 1.31)
Integrated PM2.5 5.66 0.24 (–0.14, 0.62) 0.62 (0.00, 1.25)
OC 1.61 1.12 (0.43, 1.80) 0.96 (–0.47, 2.38)
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environmental exposures and BAD in our 
study are unlikely to reflect structural effects 
of the exposures on the vasculature. Our 
study provides no evidence for endothelial-
dependent responses to pollution and weather 
because there are no consistent FMD responses 
that are independent of NMD responses. 
In the absence of supporting evidence of 
endothelium- specific influences on the brachial 
artery vasculature, we hypothesize that envi-
ronmental influences on BAD in the present 
study are likely endothelial independent, and 
may, in part, reflect autonomic responses to 
environmental exposures.
Our data (Figure 1) suggest that the domi-
nant effects of pollution on reduction of BAD 
are relatively constant even after the FMD 
maneuver, particularly 15 min later when, 
before nitroglycerin administration, the bra-
chial artery has had time to recover from the 
shear stress maneuver and come back towards 
its “baseline” diameter for the day of obser-
vation. Because the dominant and persistent 
influence of particle pollution appears to be to 
narrow the brachial artery, we do not interpret 
the small and inconsistent pollution-associated 
increases in FMD or NMD to be “beneficial.” 
We interpret the small, inconsistent and tran-
sient parti cle pollution- associated increases 
in FMD or NMD that we and others have 
seen (Liu et al. 2007; Peretz et al. 2008) to 
be mathe matically a function of the transient 
increase in arterial diameter occurring after 
the sheer stress or NMD maneuvers, in the 
context of a relatively constant influences of 
pollution on BAD narrowing.
Mean FMD in this diabetic population 
(2%) was lower than what we have measured 
in healthy adult populations [e.g., approxi-
mately 3.6% by Brook et al. (2009)]; this 
functional impairment is well documented 
and makes discernment of specific influences 
on FMD/endothelial function in this popu-
lation challenging, with a higher coefficient 
of variation of FMD compared with BAD 
(Montalcini et al. 2012). Nevertheless, in 
similar populations of people with diabetes in 
Boston, in a placebo-controlled randomized 
trial of 87 people, we were able to measure 
changes in FMD in response to troglitazone, 
an insulin-sensitizing agent (Caballero et al. 
2003). In a smaller trial of 24 people, exercise 
and weight reduction were associated with 
increased FMD (Economides et al. 2004, 
2005; Hamdy et al. 2003).
Whereas most controlled human expo-
sure chamber studies have shown concentrated 
ambient fine particle associations with reduc-
tion in BAD, chamber- (Brook et al. 2002, 
2009; Peretz et al. 2008; Urch et al. 2005) 
and community- based (Briet et al. 2007; 
Dales et al. 2007; Schneider et al. 2008a) 
 studies evaluating pollution effects on FMD 
in diabetic and non diabetic populations have 
reported inconsistent findings. Differences 
in study design, population sensitivity, par-
ticle composition-related toxicity (Brook et al. 
2009), and the higher coefficient of variation 
in FMD compared with BAD (Montalcini 
et al. 2012) have been cited as possible expla-
nations for differing study results. In a previ-
ous Boston study (O’Neill et al. 2005), we 
found cross-sectional (between-person) associ-
ations of PM2.5, BC, and SO42– with reduced 
FMD and NMD in people with diabetes but 
not in people without diabetes. These results 
supported an endothelium- independent com-
ponent to the vascular responses to pollution 
from traffic (e.g., BC) as well as non-traffic 
(e.g., SO42–) sources in people with diabetes. 
In a study in Paris, France, of healthy males 
breathing ambient air, Briet et al. (2007) also 
found that pollution from non-traffic (i.e, 
SO42–) and traffic (i.e, NO) was associated 
with reduced FMD. However, in contrast 
to the study by O’Neill (2005), NMD was 
not associated with either pollutant, support-
ing the possibility of endothelium-mediated 
mechanisms for pollu tion effects in this small 
non diabetic cohort (n = 40). This possibility 
was also supported by a prospective repeated- 
measures study in North Carolina (Schneider 
et al. 2008a) in which people with diabetes 
(n = 22) had decreased FMD in association 
with increased PM2.5, but PM2.5 was not 
significantly associated with NDM. Likely 
because of concern of potential adverse effects 
of NMD, many controlled human exposure 
and community-based studies have not mea-
sured NMD as a control (e.g., Dales et al. 
2007), making it uncertain whether an FMD 
response is endothelial dependent or not.
Sources of pollution and BAD narrowing. 
As in some of the European and North 
American studies mentioned above, our data 
suggest that pollution from non-traffic as 
well as traffic sources may influence vascu-
lar outcomes. PM2.5, BC, and OC had the 
strongest negative associations with BAD, 
whereas other exposures such as particle 
number concentration and gaseous pollutant 
concentrations showed no or less consistent 
associations with arterial diameter. The bulk 
of the OC associations that we found came 
from secondary OC [effect estimate: –0.07 
(95% CI: –0.11, –0.02)], whose sources are 
both oxidation of traffic emissions and other 
biogenic emissions (Lim and Turpin 2002), 
rather than primary OC [effect estimate: 
–0.01 (95% CI: –0.05, 0.03)], whose primary 
source is motor vehicles.
Previously, we have demonstrated asso-
ciations of pollution and temperature with 
changes in blood pressure (Hoffmann et al. 
2012). However, despite the associations of 
pollution and temperature with both BAD 
and blood pressure, these two outcomes were 
only weakly correlated (r = 0.08 and r = 0.07 
for correlations of BAD and systolic or dia-
stolic blood pressure, respectively). This is 
not surprising because BAD is measured in a 
medium-sized conduit artery, whereas blood 
pressure is mainly determined by cardiac 
output times the resistance of the arterioles, 
which were not observed directly. Thus, the 
constriction and dilation of these two sections 
of the vascular system may be subject to both 
shared and disparate physiologic mechanisms.
People with diabetes have impaired regula-
tion of vascular tone in both the micro- and 
macro vasculature. Homeostatic vascular 
responses to changes in ambient tempera-
ture and other environmental stimuli may 
be impaired in people with diabetes because 
of impaired autonomic regulation, fluid 
shifts, and medication effects. We did not 
find signifi cant departures from linearity for 
the relationship of temperature and BAD, 
suggesting that medium conduit artery vaso-
constriction occurs at lower temperatures 
as well as vasodilation at high temperatures. 
In diabetic patients, either extreme may 
be a cardiac risk factor consistent with the 
U-shaped relation of temperature with cardiac 
mortality in very cold as well as very hot 
weather (Wolf et al. 2009).
Our study was limited in size, limiting 
the power to evaluate effect modification 
by personal characteristics of this diabetic 
cohort. Our study also had limitations 
related to the precision of outcome and expo-
sure measurement. Although estimation of 
“peak diameter” by evaluating post-occlusion 
diame ter at a single point in time—60 sec 
after the cuff release—is a valid approach dat-
ing back to the classic work of Celermajer 
et al. (1992), recent work published after 
that study suggests that it may result in an 
under estimation of FMD, with potential 
for type II error (Thijssen et al. 2011). Some 
recent studies have chosen to define the peak 
diameter after cuff release, allowing the time 
to peak diameter measure to vary (Thijssen 
et al. 2011). Some of our study participants 
worked, and were not home during the day, 
so that the measurements are not called 
“personal,” but rather home/trip measure-
ments, and have their limitations as estimates 
of personal exposure. Nevertheless, this study 
design resulted in personal exposure measure-
ments during travel to the clinic, immediately 
before  outcome measurements.
Conclusions
Air  pol lut ion i s  a  l eading cause  of 
mortality and morbidity (Lim et al. 2012). 
Observational studies have shown that 
rates of cardiovascular hospitalizations and 
death in association with particle pollution 
(Zanobetti and Schwartz 2001; Zanobetti 
et al. 2009) and extreme ambient tempera-
tures (Medina-Ramón et al. 2006; Schifano 
Zanobetti et al.
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et al. 2009; Schwartz 2005) are increased 
in people with diabetes compared with the 
general population.
Our findings suggest that in people with 
type 2 diabetes, particle pollution may cause 
vasoconstriction of medium-sized conduit 
arteries, whereas higher ambient temperature 
and WVP may cause vasodilation. Our study 
provides insight into potential mechanisms 
for the clinical associations of more extreme 
environmental exposures on people with 
type 2 diabetes, a disease resulting in reduced 
ability to effectively respond to environmental 
perturbation of vascular responses relevant to 
cardiac risk.
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